May 28, 2016 12:48 PM ET

Healthcare Equipment and Supplies

Company Overview of Acelity L.P. Inc.

Company Overview

Kinetic Concepts Inc. produces surgical healing and hospital patient-mobility equipment, including a tissue-repair therapy used in hospitals in the U.S. and worldwide for acute care and serious trauma. Its wound-care and tissue-repair system is used in pulmonary care, for post-cardiac-arrest complications in the intensive-care unit, and for other types of wound treatment including failed surgical closures, amputations, and serious pressure ulcers. The system works by using a vacuum-assisted closure technology. A second product is a line of hospital equipment that provides mobility to patients who cannot move because of pulmonary complications or due to obesity. Its bariatric-care products pr...

12930 West Interstate 10

San Antonio, TX 78249

United States

Founded in 1976

5,800 Employees



Key Executives for Acelity L.P. Inc.

Chief Executive Officer, President and Director
Age: 49
Chief Financial Officer and Executive Vice President
Age: 52
Senior Vice President of Operations, Quality & Regulatory
Age: 56
President of Developed Markets
Age: 45
Group President of Businesses & Innovation
Age: 41
Compensation as of Fiscal Year 2015.

Acelity L.P. Inc. Key Developments

Acelity L.P. Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2016

Acelity L.P. Inc. announced unaudited consolidated earnings results for the first quarter ended March 31, 2016. For the quarter, total revenue was $451,366,000 against $444,050,000 a year ago. Operating earnings were $77,268,000 against $84,140,000 a year ago. Loss before income tax expense was $39,798,000 against $4,387,000 a year ago. Net loss was $25,975,000 against $4,531,000 a year ago. Net cash provided by operating activities was $78,185,000 against $102,951,000 a year ago. Additions to property, plant and equipment was $17,467,000 against $10,491,000 a year ago. Adjusted EBITDA was $161,013,000 against $165,836,000 a year ago. Net loss was $26.0 million, as reported on a GAAP basis, up from $4.5 million net loss in the prior-year period, due primarily to the impact of foreign currency exchange rate movements on the revaluation of Term E-1 EURO loan. The decline in Adjusted EBITDA was attributable to investments being made in franchise structure and sales force to drive growth, partially offset by revenue growth and expense savings associated with integration and business optimization efforts.

Acelity L.P. Inc. to Report Q1, 2016 Results on May 03, 2016

Acelity L.P. Inc. announced that they will report Q1, 2016 results at 1:42 PM, GMT Standard Time on May 03, 2016

Acelity L.P. Inc., Q1 2016 Earnings Call, May 03, 2016

Acelity L.P. Inc., Q1 2016 Earnings Call, May 03, 2016

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems, Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

December 1, 2015
Spiracur Inc., SNaP® Therapy System

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Acelity L.P. Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at